Genervon Biopharmaceuticals LLC

Release Summary

Genervon's drug candidate GM6 modulates 238 ALS-associated genes, 68 AD-associated genes and 59 PD-associated genes implicated in the pathogenesis of neurodegenerative diseases.

Genervon Biopharmaceuticals LLC